Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Analysts see a constructive Alphabet stock price prediction as cloud momentum and AI investments gain traction. The f...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
When insiders move shares, investors want to know why. This comprehensive guide breaks down why the electronic arts p...
Investors are wondering if Nvidia could double months? and what history suggests about such a rapid move. This articl...
Two high-flying stocks with more upside may fit a patient investor's long-term plan. This article dives into NVIDIA a...
CoreWeave sits at the center of the AI compute boom, offering scalable GPU capacity. This article breaks down the bul...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
When a CFO sells a sizable chunk of stock, it can raise questions about the company's outlook. This guide breaks down...